EyePoint, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
5.32
-0.08 (-1.48%)
At close: Aug 21, 2026, 4:00 PM EDT
5.30
-0.02 (-0.38%)
After-hours: Aug 21, 2026, 7:57 PM EDT
EyePoint Market Cap
EyePoint has a market cap or net worth of $458.65 million as of August 21, 2026. Its market cap has decreased by -42.19% in one year.
Market Cap
458.65M
Enterprise Value
300.54M
1-Year Change
-42.19%
Ranking
Category
Stock Price
$5.32
ChartMarket Cap Chart
Since January 27, 2005, EyePoint's market cap has increased from $388.60M to $458.65M, an increase of 18.03%. That is a compound annual growth rate of 0.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 458.60M | -69.68% |
| Dec 31, 2025 | 1.51B | 197.44% |
| Dec 31, 2024 | 508.50M | -37.68% |
| Dec 29, 2023 | 816.00M | 583.99% |
| Dec 30, 2022 | 119.30M | -66.13% |
| Dec 31, 2021 | 352.20M | 273.09% |
| Dec 31, 2020 | 94.40M | -43.68% |
| Dec 31, 2019 | 167.60M | -6.53% |
| Dec 31, 2018 | 179.30M | 266.67% |
| Dec 29, 2017 | 48.90M | -16.27% |
| Dec 30, 2016 | 58.40M | -58.82% |
| Dec 31, 2015 | 141.80M | 17.58% |
| Dec 31, 2014 | 120.60M | 12.71% |
| Dec 31, 2013 | 107.00M | 279.43% |
| Dec 31, 2012 | 28.20M | 22.08% |
| Dec 30, 2011 | 23.10M | -75.61% |
| Dec 31, 2010 | 94.70M | 44.14% |
| Dec 31, 2009 | 65.70M | 281.98% |
| Dec 31, 2008 | 17.20M | -70.19% |
| Dec 31, 2007 | 57.70M | -25.93% |
| Dec 29, 2006 | 77.90M | -62.73% |
| Dec 30, 2005 | 209.00M | -46.22% |
| Jan 27, 2005 | 388.60M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evommune | 492.48M |
| Rezolute | 486.82M |
| BlossomHill Therapeutics | 484.17M |
| Q32 Bio | 472.14M |
| Ocugen | 471.36M |
| Puma Biotechnology | 470.26M |
| Ginkgo Bioworks Holdings | 468.69M |
| Prothena Corporation | 463.57M |